Crunchbase News (1 month ago)
While the AI boom has disrupted funding patterns across the startup sphere, biotech has remained a rare steady sector for investment. For the past few years, global funding to biotech startups has hovered between $36 billion and $40 billion.
Read the full story on Crunchbase News.
Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company’s work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Fusion power plants will need a lot of lithium, and Licube is preparing to be a key supplier.
Tech bros take on the women-first dating app. What could go wrong?
Rivian spinoff Mind Robotics announced the appointment of Doug Field as president in a major coup for the EV company’s secretive robotics startup.
The next generation of super apps will likely emerge in markets where widespread mobile access, weak competition, poor financial services and crises that erode trust in banks create demand for a single trusted platform, writes guest author Nnamdi Okike, co-founder and managing partner of 645…
In a recent interview with Crunchbase News, Brendan Wallace, founder, CEO and chief investment officer of Fifth Wall, discussed the AI shift, why proptech funding totals may overlook some of the sector’s biggest investments, what it all means for founders, and the housing problems he believes still…
As the AI startup boom progresses, investors appear to be leaving few niches unfunded.
Active startup investors largely kept up or increased their dealmaking pace in the third quarter, even as overall venture funding declined with the absence of new record megarounds for AI leaders.
72 active sources
27 Turkish · 45 English
All sources
